Medical Supply Chain’s story starts with founder Samuel Lipari who exposed the artificial inflation of the hospital supply GPO’s and their monopolization inflation scheme to hospitals in a series of hearings before the US Senate Judicial Committee Subcommittee on Antitrust and in litigation against US Bancorp and the three dominant hospital supply GPOs for their monopolization of the hospital supply market that lasted over 15 years.

As a result of the senate testimony against the monopolization practices of the hospital supply GPOs to artificially inflate costs to hospitals, the US Senate Judiciary Committee amended the False Claims Act (the “FCA”) when Congress passed the Fraud Enforcement and Recovery Act (“FERA”), and passed the Patient Protection and Affordable Care Act (“PPACA) that changed to the FCA in the health care sector so that indirect federal fund recipients including hospital supply GPOs would be liable for the artificial hospital supply cost inflation fraud detailed in Lipari’s consultant testimony and litigation.